Circulating Tumor DNA detection in cancer: a comprehensive overview of current detection methods and prospects
The Oncologist · 01.09.2025 · 30 (9)
DOI: 10.1093/oncolo/oyaf204 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Oncologist, online erschienen am 18.07.2025. Verfasst von Ana Regina de Abreu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Medical Genetics, Center for Oncological Research, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Antwerp.
Abstract (Originalsprache)
Complete oveview of ctDNA detection methods.The analysis of circulating tumor DNA (ctDNA) has emerged as a major minimally invasive biomarker in oncology. Numerous methods exist for ctDNA detection and should be selected based on the specific oncological context. PCR-based methods are often preferred for their sensitivity and cost-effectiveness; however, they are limited to a narrower range of genes. In contrast, NGS-based methods enable comprehensive cancer genotyping and more efficient identification of actionable mutations. Moreover, the growing number of emerging approaches, such as third-generation sequencing and fragmentomics, highlights the increasing technical complexity of ctDNA detection. Overall, this review provides insights into the advantages and limitations of various detection strategies that can help improve clinical care for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Medical Genetics, Center for Oncological Research, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
- Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp and Antwerp University Hospital, Antwerp 2650, Belgium.
- Équipe labélisée Ligue Nationale contre le cancer, Centre de Recherche des Cordeliers, UMR-S1138, CNRS SNC5096, Université de Paris, Paris 75005, France.
- Department of Visceral and Surgical Oncology, Gustave Roussy, Cancer Campus, Villejuif 94805, France.
ORCID-Profile: Ana Regina de Abreu, Ken Op de Beeck, Guy Van Camp, Julien Taieb, Leonor Benhaim
Förderung
- University of Antwerp
Zitieren
APA
de Abreu, A. R., Wyninckx, A., Vandamme, T., Op de Beeck, K., Van Camp, G., Peeters, M., Laurent-Puig, P., Taieb, J., Taly, V., & Benhaim, L. (2025). Circulating Tumor DNA detection in cancer: a comprehensive overview of current detection methods and prospects. The Oncologist, 30(9). https://doi.org/10.1093/oncolo/oyaf204
Vancouver
de Abreu AR, Wyninckx A, Vandamme T, Op de Beeck K, Van Camp G, Peeters M, et al. Circulating Tumor DNA detection in cancer: a comprehensive overview of current detection methods and prospects. The Oncologist. 2025;30(9). doi:10.1093/oncolo/oyaf204
BibTeX
@article{deAbreu2025,
author = {de Abreu, Ana Regina and Wyninckx, Ayla and Vandamme, Timon and Op de Beeck, Ken and Van Camp, Guy and Peeters, Marc and Laurent-Puig, Pierre and Taieb, Julien and Taly, Valerie and Benhaim, Leonor},
title = {Circulating Tumor DNA detection in cancer: a comprehensive overview of current detection methods and prospects},
journal = {The Oncologist},
year = {2025},
volume = {30},
number = {9},
doi = {10.1093/oncolo/oyaf204}
}
EUVIMED